Concepedia

Publication | Open Access

A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis

DOIFull Paper Access

51

Citations

22

References

2020

Year

Teresa Coelho, David Adams, Isabel Conceição, Márcia Waddington‐Cruz, Hartmut Schmidt, Juan Buades, Josep M. Campistol, John L. Berk, Michael Polydefkis, Jing Jing Wang,
Orphanet Journal of Rare Diseases

Abstract

The study was registered at ClinicalTrials.gov (identifier: NCT01961921 ) on October 14, 2013.

References

YearCitations

Page 1